Baneocin pore. d / bed. approx. 10g # 1

Release form, composition and packaging

Powder for external use, finely dispersed, from white to yellowish.

1 g

bacitracin (as bacitracin zinc)

250 IU

neomycin (as neomycin sulfate)

5000 IU

sterilized powder base (corn starch containing no more than 2% magnesium oxide).

10 g - polyethylene cans (1) with a dispenser - cardboard packs Pharmacological action Combined antibacterial preparation for local use.

Contains two antibiotics that have a bactericidal effect, neomycin and bacitracin.

Bacitracin is a polypeptide antibiotic that inhibits the synthesis of the bacterial cell wall.

Bacitracin is especially active against gram-positive microorganisms, such as hemolytic streptococci, staphylococci, and some gram-negative pathogens.

Bacitracin resistance is extremely rare.

Neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis.

Active against gram-positive and gram-negative bacteria.

Through the use of a combination of these two antibiotics, a wide spectrum of action of the drug and synergism of action against a number of microorganisms, for example, staphylococci, are achieved.

Baneocin is well tolerated.

Tissue tolerance is considered excellent

inactivation by biological products, blood and tissue components is not observed.

If the drug is applied to large areas of skin lesions, the possibility of drug absorption and its consequences should be taken into account (see sections Side effects", "Drug interactions", "Contraindications" and "Special instructions"). Indications for use Baneocin powder is indicated for use for infections caused by microorganisms sensitive to neomycin and / or bacitracin:

bacterial skin infections of limited prevalence, for example, weeping contagious impetigo, infected trophic ulcers of the lower extremities, infected eczema, bacterial diaper dermatitis, bacterial complications of viral infections caused by Herpes simplex or Herpes zoster (including vesicle infection in chickenpox)

prevention of umbilical infection in newborns

prevention of infection after surgical (dermatological) procedures: for additional treatment in the postoperative period (after tissue excision, cauterization, episiotomy, treatment of cracks, rupture of the perineum, weeping wounds and sutures) Contraindications for use extensive skin lesions (risk of developing an ototoxic effect, accompanied by hearing loss )

severe disorders of excretory function due to cardiac or renal failure in patients with already existing lesions of the vestibular and cochlear systems in cases where absorption of the active components of the drug is possible

infections of the external auditory canal with perforation of the tympanic membrane

simultaneous use with antibiotics of the aminoglycoside group of systemic action (risk of cumulative toxicity)

hypersensitivity to bacitracin, neomycin or to other aminoglycosides and auxiliary components of the drug.

Do not use the powder to treat eye infections.

The drug should be prescribed with caution to patients with impaired liver and / or kidney function, acidosis, severe myasthenia gravis or other neuromuscular diseases. Dosing regimen The drug is used externally.

For adults and children from the 1st day of life, the drug is applied in a thin layer to the affected areas 2-4 times / day

if necessary - under the bandage.

The powder application area should not exceed 1% of the body surface area (which corresponds

Name ENG

BANEOCIN

Clinical and pharmacological group

Drug with antibacterial action for external use

ATX code

Other antibiotics for external use

Dosage

250IU / g + 5000IU / g x 10g

Structure

Active ingredients: zinc-bacitracin 250 IU, neomycin sulfate 5000 IU (5 mg)

Excipients: sterilized powder base (corn starch containing no more than 2% magnesium oxide)

Indications

Baneocin is indicated for use in infections caused by microorganisms sensitive to neomycin and / or bacitracin.

bacterial skin infections of limited prevalence, for example, with weeping contagious impetigo, infected trophic ulcers of the lower extremities, infected eczema, bacterial diaper dermatitis, bacterial complications (Herpes simplex and Herpes zoster, or chickenpox vesicles)

prevention of umbilical infection in newborns

prevention of infection after surgical (dermatological) procedures Baneocin powder can be used for additional treatment in the postoperative period (after excision, cauterization, episiotomy, for the treatment of cracks in the skin, weeping wounds and sutures).

Storage conditions and periods

At a temperature not exceeding 25 degrees, in the original packaging.

Expiration date: 2 years

Contraindications

hypersensitivity to bacitracin and / or neomycin, or to other antibiotics of the aminoglycoside series

extensive skin lesions, since absorption of the drug can cause an ototoxic effect, accompanied by hearing loss

severe disorders of excretory function due to heart or renal failure and already existing lesions of the vestibular and cochlear systems in cases where absorption of the drug is possible.

Do not use powder for eye treatment!

Carefully:

with possible absorption (extensive violations of the integrity of the skin), it is necessary to monitor the possible appearance of signs of neuromuscular blockade, especially in patients with acidosis, severe myasthenia gravis, or other neuromuscular diseases.

With the development of neuromuscular blockade, calcium supplements or neostigmine are indicated

with prolonged use of the drug, it is necessary to monitor the possible excessive growth of resistant organisms.

If this happens, appropriate treatment should be prescribed

treatment with Baneocin in patients who develop allergic reactions or superinfection should be discontinued.

INN / Active ingredient

neomycin (as sulfate), bacitracin (as zinc bacitracin)

Specifications

Scope of the drug

General

Release form

Powder

Manufacturer country

Austria

Package quantity, pcs

one

Way of introduction

On the skin

Vacation conditions

Without recipe

Brand name

Sandoz

The amount of the dosage form in the primary package

10 g

Primary packaging type

Polyethylene can with dispenser

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Combined antibiotic

Dosage form

Powder for external use

Expiration date in days

730

Package weight, g

ten

Category

:

Antibiotics

,

Antiseptics and disinfectants

,

Disinfectants

Mode of application

:

Outwardly. < br> < br> The powder is applied in a thin layer to the affected areas 2�4 times a day.

In patients with burns occupying more than 20% of the body surface, Baneocin powder should not be applied more than 1 time per day, especially in the case of decreased renal function, since absorption of the active ingredient may occur. < br> < br> When applied topically, the dose of neomycin is not should exceed 1 g / day (about 200 g of powder for external use) for 7 days. < br> < br> With a repeated course, the maximum dose is no more than 100 g.

Anatomical and therapeutic characteristics

:

D06AX Other topical antibacterials

Dosage (volume) of the substance in the preparation

:

bacitracin (as zinc bacitracin) 250 IU, neomycin (as neomycin sulfate) 5000 IU

Information on technical characteristics, delivery set, country of manufacture "